THE ONLY ANTIRETROVIRAL WITH A CONVENIENT HCP TOUCHPOINT EVERY 2 WEEKS

New convenient 30-second IV PUSH administration for TROGARZO® administered every 2 weeks.

TROGARZO® is used in combination with other antiretroviral(s). Every TROGARZO® vial contains 200 mg.

PATIENTS WHO ACHIEVED HIV RNA < 50 COPIES/ML AT WEEK 24 MAINTAINED VIRAL SUPPRESSION UP TO WEEK 48.

LOADING DOSE
2000 mg

2000 mg
(10 vials)

30 Minutes Clock

30 min
infusion

Magnifying Glass Eye

1 hr
observation

MAINTENANCE DOSE
800 mg

800 mg
(4 vials)

15 Minutes Clock

30s IV Push or
15 min infusion

Magnifying Glass Eye

15 min
observation

AFTER INITIAL LOADING DOSE INFUSION,

new convenient 30-second iv push administration for maintenance dose3‡

  • Administration simplicity for HCPs and patients
  • No dilutions required
  • Less preperation time compared to current method of IV infusion

CONVENIENT OPTIONS FOR
PATIENT ADMINISTRATION*

Briefcase

OFFICE

House

HOME

Hospital

HOSPITAL/IV CENTERS

Explore Available Access & Support

* Dependant on insurance coverage.

‡ Study design and results: Open-label, non-randomized study in clinically stable patients while on TROGARZO®-containing ARV regimens for at least 3 months (N=9) and HIV-uninfected individuals (N=10). All subjects received TROGARZO® maintenance dose as IV infusion and IV Push, and pharmacokinetics (PK), safety, and efficacy were evaluated. Bioequivalence was demonstrated between IV infusion and IV Push methods of administration and IV Push over 30-seconds was safe and well tolerated.